Without a new approach to developing and pricing new tuberculosis (TB) medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis (DR-TB), warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the Union World Conference on Lung Health in Paris.
“If I could change anything about having TB it would be the treatment; if we could have less toxic drugs and simpler, shorter treatment regimens, there would be fewer people dropping out of treatment and fewer people dying,” said Phumeza Tisile, who received
TB treatment through MSF’s program in Khayelitsha, South Africa.
In December 2012, a 50-year drought in TB drug research and development (R&) came to,read more;http://eyesawmagazine..com/2013/11/first-new-tb-drug-in-fifty-years-risks.html